Lentivirally Redirected CD123 Autologous T Cells

· University of Pennsylvania

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lentivirally Redirected CD123 Autologous T Cells, covering 2025-06-26 to 2025-06-26. Get the full timeline:

Most recent: Clinical Trial Update: Lentivirally Redirected CD123 Autologous T Cells in AML [Phase 1]